companydata.dkOLANDER CLINICAL CONSULTING K/S: Financial statements 2022
CVR: 35860177
OLANDER CLINICAL CONSULTING K/S (CVR 35860177) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 1,919,291 and a net result of DKK 1,880,355 compared with DKK 1,758,667 the year before. That is an increase of 6.7% compared with the year before. Equity amounted to DKK 621,486. The solvency ratio was 75.9%.
- Gross Profit
- 1,919,291 kr.
- Profit/Loss
- 1,880,355 kr.
- Equity
- 621,486 kr.
- Total Assets
- 818,336 kr.
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 1.9 mio. | 1.9 mio. | 621 t. | - |
| 2021 | - | 1.8 mio. | 1.8 mio. | 687 t. | - |
| 2020 | - | 1.5 mio. | 1.5 mio. | 461 t. | - |
| 2019 | - | 1.4 mio. | 1.4 mio. | 491 t. | - |
| 2018 | - | 1.7 mio. | 1.7 mio. | 700 t. | - |
Keep an eye on OLANDER CLINICAL CONSULTING K/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
OLANDER CLINICAL CONSULTING K/S has published its annual report for 2021. Gross profit came to DKK 1,798,004, and the net result was DKK 1,758,667.
About OLANDER CLINICAL CONSULTING K/S
OLANDER CLINICAL CONSULTING K/S is a Danish company of the type Kommanditselskab based in Snekkersten, founded in 2014. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The management consists of Birgitte Aae Olander. The company is owned by Birgitte Aae Olander. In 2025, the company reported a gross profit of DKK 2,099,449 and a net result of DKK 2,057,637 compared with DKK 2,004,688 the year before. Equity amounted to DKK 303,261.